CFTR and inflammation: Additionally, we also evaluated the pre-clinical therapeutic efficacy of SAHA in controlling Pa-LPS induced neutrophil activity and lung inflammation in Cftr+/+ and Cftr−/−-gut-corrected (Figs. 4, 5a and b, Fig. 6) murine models of airway-inflammation and chronic-CF lung disease [16].